Publication | Open Access
Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: the EMPATROPISM-FE trial
18
Citations
41
References
2024
Year
NCT03485222 (www.clinicaltrials.gov).
| Year | Citations | |
|---|---|---|
Page 1
Page 1